Collection

European Pharmacopoeia Chapter 2.1.7

Collection

Ensure Compliance with "Balances for Analytical Purposes"

European Pharmacopeia Chapter 2.1.7 Publication Schedule
European Pharmacopeia Chapter 2.1.7 Publication Schedule

Webinar: Compliance with Ph. Eur. Chapter 2.1.7


This webinar explains the new European Pharmacopoeia General Chapter 2.1.7 "Balances for Analytical Purposes". For compliant weighing, balances must be calibrated periodically, including measurement uncertainty, and performance checks for repeatability and accuracy are a requirement.

Watch the Webinar on Ph. Eur. Chapter 2.1.7

The new General Chapter 2.1.7 "Balances for Analytical Purposes" was published in July 2021 as part of the European Pharmacopoeia (Ph. Eur.) Supplement 10.6. 

 

What is new?

General Chapter 2.1.7:

  • States that the calibration results must be documented in a calibration certificate and must include measurement uncertainty.
  • Highlights the importance of as found and as left calibration.
  • Focuses on best practices for installation and usage of the instruments.
  • Supports life-cycle management comprised of calibration and performance verification based on specific tests and acceptance criteria.

 

When will the Ph. Eur. General Chapter 2.1.7 be legally binding?

After a 6-month transition phase, the chapter is legally binding and is enforced in the framework of GMP audits by regulatory bodies from January 2022 onwards.

 

How can METTLER TOLEDO support you?

As the calibration of balances is a mandatory requirement of General Chapter 2.1.7, METTLER TOLEDO launches the new certificate "European Pharmacopoeia General Chapter 2.1.7 Balances for Analytical Purposes". The certificate documents the assessment of a balance against the requirements stipulated for precision and accuracy. This assessment is also available in an independent document against the identical requirements stipulated by USP General Chapter 41.

Have a Look at a Sample Certificate

 

Who is affected by Ph. Eur. General Chapter 2.1.7?

The European Pharmacopoeia (Ph. Eur.) is the single reference work for the quality control of drugs in 39 European countries. It is therefore also binding for pharmaceutical companies in other regions of the world who intend to export into the European market. As such, it has a similar legal status to the USP Compendium in the United States and is enforced by regulatory bodies as part of compliance with Good Manufacturing Practice. 

Video